ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GITENDRA RAJIYAH M.D.

Cardiovascular Disease

21,279

$1.61M

972
691 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 33%

$76
Average prescription price

Avg: $88

AHMAD KAHF MD

Cardiovascular Disease

16,176

$1.26M

562
361 are 65+

16%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 33%

$78
Average prescription price

Avg: $88

ALEJANDRO PRESILLA MD

Cardiovascular Disease

14,986

$979K

301
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 33%

$65
Average prescription price

Avg: $88

JOSE SANTANA M.D.

Cardiovascular Disease

14,443

$1.09M

973
865 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 33%

$76
Average prescription price

Avg: $88

FRANK SHANLEY D.O.

Cardiovascular Disease

14,089

$874K

344
321 are 65+

14%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 33%

$62
Average prescription price

Avg: $88

CARLOS ALCORTA MD, FACC

Cardiovascular Disease

12,542

$934K

388
365 are 65+

12%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 33%

$74
Average prescription price

Avg: $88

ANTHONY INGUAGGIATO MD

Cardiovascular Disease

11,903

$999K

363
334 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 33%

$84
Average prescription price

Avg: $88

JOSEPH LAURICELLA M.D.

Cardiovascular Disease

11,493

$673K

626
590 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 33%

$59
Average prescription price

Avg: $88

LAWRENCE ANTONUCCI MD

Cardiovascular Disease

10,734

$1.38M

988
931 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 33%

$129
Average prescription price

Avg: $88

MUHAMMAD AHMAD M.D.

Cardiovascular Disease

10,698

$927K

389
334 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 33%

$87
Average prescription price

Avg: $88

LEONARD FEITELL M.D.

Cardiovascular Disease

10,182

$692K

484
405 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 33%

$68
Average prescription price

Avg: $88

MATHEW CHOLANKERIL MD

Cardiovascular Disease

10,100

$728K

618
505 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 33%

$72
Average prescription price

Avg: $88

FELIX DAILEY-STERLING M.D.

Cardiovascular Disease

9,399

$1.01M

676
578 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 33%

$108
Average prescription price

Avg: $88

BHUDEV SHARMA M.D.

Cardiovascular Disease

9,169

$759K

549
496 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 33%

$83
Average prescription price

Avg: $88

JOHN STROBECK MD, PHD

Cardiovascular Disease

8,890

$745K

671
628 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 33%

$84
Average prescription price

Avg: $88

JASJIT WALIA M.D

Cardiovascular Disease

8,734

$738K

845
654 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 33%

$84
Average prescription price

Avg: $88

RICK PUMILL M.D.

Cardiovascular Disease

8,164

$857K

626
565 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 33%

$105
Average prescription price

Avg: $88

MICHAEL AARON D.O.

Cardiovascular Disease

8,143

$770K

932
853 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 33%

$95
Average prescription price

Avg: $88

PREET RANDHAWA M.D

Cardiovascular Disease

7,978

$494K

625
509 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 33%

$62
Average prescription price

Avg: $88

AVINASH GUPTA MD

Cardiovascular Disease

7,967

$1.1M

757
671 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 33%

$139
Average prescription price

Avg: $88

EDWIN BLUMBERG MD

Cardiovascular Disease

7,957

$744K

548
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 33%

$93
Average prescription price

Avg: $88

JEFFREY DANIELS MD

Cardiovascular Disease

7,889

$844K

716
663 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 33%

$107
Average prescription price

Avg: $88

BARRY SHAPIRO D.O.

Cardiovascular Disease

7,772

$788K

565
481 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 33%

$101
Average prescription price

Avg: $88

JOANNE MARTIN M.D.

Cardiovascular Disease

7,751

$566K

303
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 33%

$73
Average prescription price

Avg: $88

NICHOLAS DEPACE MD

Cardiovascular Disease

7,694

$632K

649
528 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 33%

$82
Average prescription price

Avg: $88

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank